Odds and Ends of Practical Pharmacology
Odds and Ends of Practical Pharmacology

Author: Cyrus M. Babcock

Publisher: Kessinger Publishing

Published: 2008-10-01

Total Pages: 50

ISBN-13: 9781437025101

DOWNLOAD EBOOK

This scarce antiquarian book is a facsimile reprint of the original. Due to its age, it may contain imperfections such as marks, notations, marginalia and flawed pages. Because we believe this work is culturally important, we have made it available as part of our commitment for protecting, preserving, and promoting the world's literature in affordable, high quality, modern editions that are true to the original work.

Homeopathy in Healthcare
Homeopathy in Healthcare

Author: Gudrun Bornhöft

Publisher: Springer Science & Business Media

Published: 2011-12-09

Total Pages: 237

ISBN-13: 3642206379

DOWNLOAD EBOOK

This volume includes the full Health Technology Assessment (HTA) report on effectiveness, appropriateness, safety and costs of homoeopathy in health care. The report was commissioned by the Swiss health authorities to inform decision-making on the further inclusion of homoeopathy in the list of services covered by statutory health insurance. Other studies carried out as part of the Swiss Complementary Medicine Evaluation Programme (PEK) caused a massive stir due to their schematic and exclusively quantitative (negative-)outcomes for homoeopathy. The present report, in contrast, offers a differentiated evaluation of the practice of homoeopathy in health care. It confirms homoeopathy as a valuable addition to the conventional medical landscape – a status it has been holding for a long time in practical health care.

Pain Management and the Opioid Epidemic
Pain Management and the Opioid Epidemic

Author: National Academies of Sciences, Engineering, and Medicine

Publisher: National Academies Press

Published: 2017-09-28

Total Pages: 483

ISBN-13: 0309459575

DOWNLOAD EBOOK

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.